Expression of transforming growth factor-β (TGF-β) isoforms in osteosarcomas: TGF-β3 is related to disease progression

Cancer

Volumn 80, Issue 12, 1997, Pages 2230-2239

  Kloen, Peter ^a   Gebhardt, Mark C ^a   Perez Atayde, Antonio ^b   Rosenberg, Andrew E ^a   Springfield, Dempsey S ^a,d   Gold, Leslie I ^c   Mankin, Henry J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c NEW YORK UNIVERSITY   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Disease progression; Immunohistochemistry; Osteosarcoma; Transforming growth factor

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ADOLESCENT; ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; OSTEOSARCOMA; PREVALENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION;

EID: 0031470962     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19971215)80:12<2230::AID-CNCR3>3.0.CO;2-Y     Document Type: Article

References (48)

1. Roberts AB, Sporn MB. Peptide growth factors and their receptors. In: Roberts AB, Sporn MB, editors. Handbook of experimental pharmacology. Heidelberg: Springer-Verlag, 1990:419-72.
2. Assioan RK, Komoriya A, Meyers CA, Miller DM, Sporn MB. Transforming growth factor-beta in human platelets. J Cell Biochem 1983;258:7155-66.
3. Heine UI, Munoz EF, Flanders KC, Ellingsworth LR, Lam H-YP, Thompson NL, et al. Role of transforming growth factor-β in the development of the mouse embryo. J Cell Biol 1987; 105:2861-76.
4. Pelton RW, Saxena B, Jones M, Moses HL, Gold LI. Immunohistochemical localization of TGFβ1, TGFβ2, and TGFβ3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell Biol 1991;115: 1091-105.
5. Centrella M, Horowitz MC, Wozney JM, McCarthy TL. Transforming growth factor-β gene family members and bone. Endocr Rev 1994;15:27-39.
6. Robey PG, Young MF, Flanders KC, Roche NS, Kondaiah P, Reddi HA, et al. Osteoblasts synthesize and respond to transforming growth factor-type β (TGF-β) in vitro. J Cell Biol 1987;105:457-63.
7. Beck LS, Amento EP, Deguzman L, Lee WP, Ngyen T, Gillett NA. TGF-β1 induces bone closure of skull defects: temporal dynamics of bone formation in defects exposed to rh-TGF-β1. J Bone Miner Res 1993;8:753-61.
8. Beck LS, Deguzman L, Lee WP, Xu Y, McFatridge LA, Gillett NA, et al. TGF-β1 induces bone closure of skull defects. J Bone Miner Res 1990;6:1257-65.
9. Joyce ME, Roberts AB, Sporn MB, Bolander ME. Transforming growth factor-β and the initiation of chondrogenesis and osteogenesis in the rat femur. J Cell Biol 1990;110: 2195-207.
10. Erlebacher A, Derynck R. Increased expression of TGF-β2 in osteoblasts results in an osteoporosis-like phenotype. J Cell Biol 1996;132:195-210.
11. Ciernik FI, Krayenbuhl-Ciernik BH, Cockerell CJ, Minna JD, Gazdar AF, Carbone DP. Expression of transforming growth factor β receptors on AIDS-associated Kaposi's sarcoma. Clin Cancer Res 1995;1:1119-24.
12. Friess H, Yamanaka Y, Büchler M, Ebert M, Beger HG, Gold LI, et al. Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 1993;105:1846-56.
13. Gold LI, Korc M. Expression of transforming growth factor-β1,2 and 3 mRNA and protein in human cancers. Dig Surgery 1994;11:150-6.
14. Gold LI, Saxena B, Mittal KR, Marmor M, Goswami S, Nactigal L, et al. Increased expression of transforming growth factor β isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium: evidence for paracrine and autocrine action. Cancer Res 1994;54:2347-58.
15. Gorsch SM, Memoli VA, Stukel TA, Gold LI, Arrick BA. Immunohistochemical staining for transforming growth factor β1 associates with disease progression in human breast cancer. Cancer Res 1992;52:6949-52.
16. Jennings MT, Kaariainen IT, Gold L, Maciunas RJ, Commers PA. TGF-β1 and TGF-β2 are potential growth regulators for medulloblastomas, primitive neuroectodermal tumors, and ependymomas: evidence in support of an autocrine hypothesis. Hum Pathol 1994;25:464-75.
17. Jennings MT, Maciunas RJ, Carver R, Bascom CC, Juneau P, Misulis K, et al. TGF-β1 and TGF-β2 are potential growth regulators for low-grade and malignant gliomas in vitro: evidence in support of an autocrine hypothesis. Int J Cancer 1991;49:129-39.
18. Johnson MD, Federspiel CF, Gold LI, Moses HL. Transforming growth factor-β and Transforming growth factor-β-receptor expression in human meningioma cells. Am J Pathol 1992;141:633-42.
19. McCune BK, Patterson K, Chandra RS, Kapur S, Sporn MB, Tsokos M. Expression of transforming growth factor-β isoforms in small round cell tumors of childhood. Am J Pathol 1993;142:49-59.
20. Nakatsukasa H, Evarts RP, Hsia C, Marsden E, Thorgeirsson SS. Expression of transforming growth factor β1 during chemical hepatocarcinogenesis in the rat. Lab Invest 1991; 65:511-7.
21. Robson H, Anderson E, James RD, Schofield PF. Transforming growth factor β1 expression in human colorectal tumours: an independent prognostic marker in a subgroup of poor prognosis patients. Br J Cancer 1996;74:753-8.
22. Schwarz LC, Wright JA, Gingras M, Kondaiah P, Danielpour D, Pimentel M, et al. Aberrant TGF-β production and regulation in metastatic malignancy. Growth Factors 1990;3:115-27.
23. Steiner MS, Zhou Z, Tonb DC, Barrack ER. Expression of transforming growth factor-β1 in prostate cancer. Endocrinology 1994;135:2240-7.
24. Takanami I, Imamura T, Hashizume T, Kikuchi K, Yamamoto Y, Kodaira S. Transforming growth factor β1 as a prognostic factor in pulmonary adenocarcinoma. J Clin Pathol 1994;47:1098-100.
25. Tsushima H, Kawata S, Tamura S, Ito N, Shirai Y, Kiso S, et al. High levels of transforming growth factor β1 in patients with colorectal cancer: association with disease progression. Gastroenterology 1996;110:375-82.
26. Williams AO, Ward JM, Li JF, Jackson MA, Flanders KC. Immunohistochemical localization of transforming growth factor-β1 in Kaposi's sarcoma. Hum Pathol 1995;26:469-73.
27. Folkman J. Clinical applications of research on angiogenesis. N Engl J Med 1995;333:1757-63.
28. Roberts AB, Sporn MB, Assoian RK. Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986;83:4167-71.
29. Torre-Amione G, Beauchamp RD, Koeppen H, Park BH, Schreiber H, Moses HL. A highly immunogenic tumor transfected with a murine transforming growth factor type b1 cDNA escapes immune surveillance. Proc Natl Acad Sci USA 1990;87:1486-90.
30. Fuegeas O, Guriec N, Babin-Boilletot A, Marcellin L, Simon P, Thyss A. Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma. J Clin Oncol 1996;14:467-72.
31. Grundmann E, Rossner A, Ueda Y, Schneider-Stock R, Radig K. Current aspects of the pathology of osteosarcoma. Anticancer Res 1995;15:1023-33.
32. Miller CM, Aslo A, Tsay C, Slamon D, Ishizaki K, Toguchida J, et al. Frequency and structure of P53 rearrangements in human osteosarcoma. Cancer Res 1990;50:7950-4.
33. Sekyi-Otu A, Bell RS, Ohashi C, Pollak M, Andrulis IL. Insulin-like growth factor 1 (IGF-1), and IGF-2 are expressed in primary human sarcomas. Cancer Res 1995;55:129-34.
34. Graves DT, Owen AJ, Barth RK, Tempst P, Winoto A, Fors L. Detection of c-cis transcripts and synthesis of PDGF-like proteins by human osteosarcoma cells. Science 1984;226: 972-4.
35. Kloen P, Jennings CL, Gebhardt MC, Springfield DS, Mankin HJ. Expression of transforming growth factor-beta (TGF-β) receptors, TGF-β1 and TGF-β2 production and autocrine growth control in osteosarcoma cells. Int J Cancer 1994;58: 440-5.
36. Bauer FCH, Urist MR. Human osteosarcoma-derived soluble bone morphogenetic protein. Clin Orthop 1980;154:291-5.
37. Yoshikawa H, Rettig WJ, Lane JM, Takaoka K, Alderman E, Rup B, et al. Immunohistochemical detection of bone morphogenetic proteins in bone and soft-tissue sarcomas. Cancer 1994;74:842-7.
38. Yoshikawa H, Rettig WJ, Takaoka K, Alderman E, Rup B, Rosen V, et al. Expression of bone morphogenetic proteins in human osteosarcoma. Cancer 1994;73:85-91.
39. Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop 1980;153:44-6.
40. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
41. Thorp BH, Anderson I, Jakowlew SB. Transforming growth factor-β1, -β2, -β3 in cartilage and bone cells during endochondral ossification in the chick. Development 1992;114: 907-11.
42. Roberts AB, Sporn MB. TGF-β: possible roles in carcinogenesis. Br J Cancer 1988;57:594-600.
43. VanObberghen-Schilling E, Roche NS, Flanders KC, Sporn MB Roberts AB. Transforming growth factor-β1 positively regulates its own expression in normal and transformed cells. J Biol Chem 1988;263:7741-6.
44. Chang H, Gillett N, Figari I, Lopez AR, Palladino MA, Derynck R. Increased transforming growth factor β expression inhibits cell proliferations in vitro, yet increases tumorigenicity and tumor growth of Meth A sarcoma cells. Cancer Res 1993;53:4391-8.
45. Barton R, Neff L, Louvard CA, Courtoy PJ. Cell-mediated extracellular acidification and bone resorption: evidence for a low pH in resorbing lacunae and localization of a 100 kD lysosomal membrane protein at the osteoclast ruffled border. J Cell Biol 1985;101:2210-22.
46. Wakefield LM, Letterio JJ, Chen T, Danielpour D, Allison RSH, Pai LH, et al. Transforming growth factor-β1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancer. Clin Cancer Res 1995;1:129-36.
47. Davis AM, Bell RS, Goodwin RJ. Prognostic factors in osteosarcoma: a critical review. J Clin Oncol 1994;12:423-31.
48. Baldini N, Scotlandi D, Barbanti-Brodani G, Manara MC, Aurici D, Bacci G, et al. Expression of P-glycoprotein in high-grade osteosarcoma in relation to clinical outcome. N Engl J Med 1995;23:1380-5.